BF Biosciences Limited (PSX:BFBIO)
131.73
-1.47 (-1.10%)
At close: Jul 17, 2026
-20.86% (1Y)
| Market Cap | 11.64B -20.9% |
| Revenue (ttm) | 8.86B +78.7% |
| Net Income | 591.76M +51.1% |
| EPS | 6.70 +27.8% |
| Shares Out | 88.33M |
| PE Ratio | 19.66 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 58,257 |
| Open | 133.20 |
| Previous Close | 133.20 |
| Day's Range | 131.51 - 134.00 |
| 52-Week Range | 124.00 - 189.97 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 22, 2026 |